Article
Cytochrome P450 polymorphisms as risk factors for steroid hormone-related cancers.
American journal of pharmacogenomics : genomics-related research in drug development and clinical practice - 1 Jan 2001
Friedberg T
Abstract excerpt
The development of cancers of the breast, endometrium, ovaries and possibly prostate is modulated by steroid hormones. Many steroids and environmental carcinogens are subject to cytochrome P450 (P450)-mediated metabolism that generates reactive metabolites and modulates steroid potency, thereby influencing tumor initiation and promotion respectively. These pathways, which are modulated by polymorphisms in P450...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
